Literature DB >> 26005023

(±) cis-Bisamido epoxides: A novel series of potent FXIII-A inhibitors.

Craig A Avery1, Richard J Pease2, Kerrie Smith2, May Boothby2, Helen M Buckley2, Peter J Grant2, Colin W G Fishwick3.   

Abstract

A novel class of potent FXIII-A inhibitors containing a (±) cis-bisamido epoxide pharmacophore is described. The compounds display highly potent inhibition of FXIII-A (IC50 = 5-500 nM) in an in vitro assay. In contrast to other types of previously described covalent transglutaminase inhibitors, the bis-amido epoxides exhibited no measurable reactivity with glutathione, therefore possibly rendering this class of compounds suitable for future in vivo investigations. Additionally, the compounds show selective inhibition for FXIII-A against the cysteine protease, cathepsin S although they proved to have similar potency with a closely related transglutaminase, TGII, to that observed for FXIII-A.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Bis-amido epoxides molecular modelling; FXIII-A; Thrombosis

Mesh:

Substances:

Year:  2015        PMID: 26005023     DOI: 10.1016/j.ejmech.2015.05.019

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  5 in total

Review 1.  Factor XIIIa inhibitors as potential novel drugs for venous thromboembolism.

Authors:  Rami A Al-Horani; Srabani Kar
Journal:  Eur J Med Chem       Date:  2020-05-18       Impact factor: 6.514

2.  Identification of a lead like inhibitor of the hepatitis C virus non-structural NS2 autoprotease.

Authors:  Joseph Shaw; Mark Harris; Colin W G Fishwick
Journal:  Antiviral Res       Date:  2015-11-09       Impact factor: 5.970

3.  The Plasma Factor XIII Heterotetrameric Complex Structure: Unexpected Unequal Pairing within a Symmetric Complex.

Authors:  Sneha Singh; Alexis Nazabal; Senthilvelrajan Kaniyappan; Jean-Luc Pellequer; Alisa S Wolberg; Diana Imhof; Johannes Oldenburg; Arijit Biswas
Journal:  Biomolecules       Date:  2019-11-21

4.  NMR-Based Structural Characterization of a Two-Disulfide-Bonded Analogue of the FXIIIa Inhibitor Tridegin: New Insights into Structure-Activity Relationships.

Authors:  Thomas Schmitz; Ajay Abisheck Paul George; Britta Nubbemeyer; Charlotte A Bäuml; Torsten Steinmetzer; Oliver Ohlenschläger; Arijit Biswas; Diana Imhof
Journal:  Int J Mol Sci       Date:  2021-01-17       Impact factor: 5.923

Review 5.  Factor XIII-A: An Indispensable "Factor" in Haemostasis and Wound Healing.

Authors:  Fahad S M Alshehri; Claire S Whyte; Nicola J Mutch
Journal:  Int J Mol Sci       Date:  2021-03-17       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.